AI
Altimmune Inc
🇺🇸XNAS.ALTUnited StatesHealthcare
$3.27USDup +0.04 (+1.24%)OpenDelayed5:39 PM
Price$3.27+0.04 (+1.24%)
Profile
- Healthcare
- Biotechnology
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- US02155H2004
- CUSIP
- 42224H203
Company
- Employees
- 57
- Headquarters
- Gaithersburg, United States
- Website
- https://altimmune.com
- CEO
- Mr. Jerome Benedict Durso
Market
- Shares outstanding
- 194.5M
- Market cap
- $636.07M
Key dates
- Next earnings
- Nov 5, 2026
Highlights
- Market cap
- $630.24M
- EPS LTM
- -$0.47calculatedCalculated by Finzer, not reported by the data provider.
- P/E LTM
- -6.93calculatedCalculated by Finzer, not reported by the data provider.
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $31K+55%up year on year
- Net income
- -$91.76M-4.57%down year on year
- Gross margin
- -48,390.32%-11,997.58%down year on year
- Free cash flow
- -$76.56M+6.15%up year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.